Mads Krogs­gaard Thom­sen hands off CSO job at No­vo Nordisk af­ter a 30-year run, then piv­ots to CEO post at huge No­vo Foun­da­tion

An­oth­er long­time Big Phar­ma R&D chief is hit­ting the ex­it.

No­vo Nordisk put out word this morn­ing that at the end of this month, the 30-year vet Mads Krogs­gaard Thom­sen will leave his post as EVP and chief sci­en­tif­ic of­fi­cer for No­vo. Mar­cus Schindler is be­ing pro­mot­ed to CSO and EVP for re­search & ear­ly de­vel­op­ment while Mar­tin Holst Lange steps up to his new role as EVP for de­vel­op­ment.

Thom­sen joined the com­pa­ny all the way back in 1991 as head of growth hor­mone re­search, when he was 31 years old, then moved up to di­a­betes re­search in 1994 and CSO 21 years ago.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER